CareDx Q1 revenue $72M (-7% YoY); raises FY2024 revenue guidance to $274-282M

CareDx, Inc.

2024-Q1 EPS reported -$0.32 revenue$72,049,000

Revenue $72.0M, down 7% YoY from $77.3M but up 10% sequentially from Q4 2023.
Net loss $16.7M ($0.32 loss per share) improved from $23.7M loss ($0.44) a year ago.
Testing Services revenue $53.8M, down 13% YoY but up 15% sequentially; patient results ~42,000, up 6% sequentially.
Adjusted EBITDA loss $1.9M vs $6.4M loss in Q1 2023 and $10.3M loss in Q4 2023.
Raises FY2024 revenue guidance to $274-282M; cash $216M with no debt.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

CareDx, Inc. reported the first quarter ended March 31, 2024 results: revenue $72.0 million, net income net loss was $16.7 million, EPS $0.32. Guidance raised.

Period: the first quarter ended March 31, 2024
Revenue: $72.0 million
Net income: net loss was $16.7 million
EPS: $0.32
Guidance: raised
Result: reported results

Exact text from the filing

CareDx, Inc. (Nasdaq: CDNA) — today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights • Reported first quarter revenue of $72.0 million. • Revenue for Testing Services of $53.8 million, an increase of 15% as compared to the fourth quarter 2023. • Grew testing services patients results for the third consecutive

View on SEC.gov

1053 earnings releases filed in the last 30 days. Browse all earnings releases →

CareDx, Inc. filing history →

Source: SEC EDGAR

accession 0001217234-24-000062

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.